354 related articles for article (PubMed ID: 34526098)
1. circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma.
Xu YP; Dong ZN; Wang SW; Zheng YM; Zhang C; Zhou YQ; Zhao YJ; Zhao Y; Wang F; Peng R; Tang MC; Bai DS; Huang XY; Guo CY
J Exp Clin Cancer Res; 2021 Sep; 40(1):290. PubMed ID: 34526098
[TBL] [Abstract][Full Text] [Related]
2. CircRTN4IP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production.
Tang J; Wang R; Tang R; Gu P; Han J; Huang W
Pathol Res Pract; 2022 Feb; 230():153732. PubMed ID: 34974242
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis.
Lei GL; Li Z; Li YY; Hong ZX; Wang S; Bai ZF; Sun F; Yan J; Yu LX; Yang PH; Yang ZY
Environ Toxicol; 2021 Nov; 36(11):2322-2332. PubMed ID: 34418280
[TBL] [Abstract][Full Text] [Related]
4. CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis.
Zhen N; Gu S; Ma J; Zhu J; Yin M; Xu M; Wang J; Huang N; Cui Z; Bian Z; Sun F; Pan Q
Theranostics; 2019; 9(3):900-919. PubMed ID: 30809316
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1.
Li J; Xu X; Xu K; Zhou X; Wu K; Yao Y; Liu Z; Chen C; Wang L; Sun Z; Jiao D; Han X
J Exp Clin Cancer Res; 2024 Apr; 43(1):119. PubMed ID: 38641828
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
[TBL] [Abstract][Full Text] [Related]
7. Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression.
Sun J; Feng M; Zou H; Mao Y; Yu W
Histol Histopathol; 2023 Oct; 38(10):1129-1143. PubMed ID: 36331285
[TBL] [Abstract][Full Text] [Related]
8. Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma.
Xu Y; Yao Y; Liu Y; Wang Z; Hu Z; Su Z; Li C; Wang H; Jiang X; Kang P; Sun D; Zhong X; Cui Y
Aging (Albany NY); 2019 Apr; 11(7):1907-1917. PubMed ID: 30946694
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription.
Chen Q; Wang H; Li Z; Li F; Liang L; Zou Y; Shen H; Li J; Xia Y; Cheng Z; Yang T; Wang K; Shen F
J Hepatol; 2022 Jan; 76(1):135-147. PubMed ID: 34509526
[TBL] [Abstract][Full Text] [Related]
10. Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma.
Sun BY; Yang ZF; Wang ZT; Liu G; Zhou C; Zhou J; Fan J; Gan W; Yi Y; Qiu SJ
World J Surg Oncol; 2023 Mar; 21(1):90. PubMed ID: 36899373
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
12. A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers.
Xu Y; Leng K; Yao Y; Kang P; Liao G; Han Y; Shi G; Ji D; Huang P; Zheng W; Li Z; Li J; Huang L; Yu L; Zhou Y; Jiang X; Wang H; Li C; Su Z; Tai S; Zhong X; Wang Z; Cui Y
Hepatology; 2021 Apr; 73(4):1419-1435. PubMed ID: 32750152
[TBL] [Abstract][Full Text] [Related]
13. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.
Qi Y; Wang D; Huang W; Wang B; Huang D; Xiong F; Chen X; Chen Y
J Exp Clin Cancer Res; 2019 Oct; 38(1):413. PubMed ID: 31590696
[TBL] [Abstract][Full Text] [Related]
14. MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.
Zu C; Liu S; Cao W; Liu Z; Qiang H; Li Y; Cheng C; Ji L; Li J; Li J
Oncotarget; 2017 May; 8(21):34698-34708. PubMed ID: 28423728
[TBL] [Abstract][Full Text] [Related]
15. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation.
Xu Y; Gao P; Wang Z; Su Z; Liao G; Han Y; Cui Y; Yao Y; Zhong X
J Cell Mol Med; 2021 Apr; 25(7):3226-3238. PubMed ID: 33675150
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive circular RNA expression profiling constructs a ceRNA network and identifies hsa_circ_0000673 as a novel oncogene in distal cholangiocarcinoma.
Zhao X; Zhang X; Zhang Z; Liu Z; Zhu J; Lyu S; Li L; Lang R; He Q
Aging (Albany NY); 2020 Nov; 12(22):23251-23274. PubMed ID: 33221765
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of tissue-resident CD8
Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
Huang YH; Zhang CZ; Huang QS; Yeong J; Wang F; Yang X; He YF; Zhang XL; Zhang H; Chen SL; Zheng YL; Deng R; Lin CS; Yang MM; Li Y; Jiang C; Kin-Wah Lee T; Ma S; Zeng MS; Yun JP
J Hepatol; 2021 Apr; 74(4):838-849. PubMed ID: 33212090
[TBL] [Abstract][Full Text] [Related]
19. CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma.
Du J; Lan T; Liao H; Feng X; Chen X; Liao W; Hou G; Xu L; Feng Q; Xie K; Liao M; Chen X; Huang J; Yuan K; Zeng Y
Mol Cancer; 2022 Jan; 21(1):18. PubMed ID: 35039066
[TBL] [Abstract][Full Text] [Related]
20. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
